SCHEMBL9996394

SCHEMBL9996394

CCNC(=O)CCCC(O)(c1cccc(Cl)c1)C1CCCNC1

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
REN P00797 16/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9996391 1.00 REN (0.47) REN
SCHEMBL3605969 0.90 REN (0.45) REN
SCHEMBL3605975 0.90 REN (0.45) REN
SCHEMBL1863977 0.89 REN (0.57) REN
SCHEMBL1863979 0.89 REN (0.57) REN
SCHEMBL27709552 0.89 REN (0.57) REN
SCHEMBL1862228 0.86 REN (0.56) REN
SCHEMBL1862226 0.86 REN (0.56) REN
SCHEMBL27689840 0.86 REN (0.56) REN
SCHEMBL3616993 0.86 REN (0.42) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101356156-B Aspartic protease inhibitors VITAE PHARMACEUTICALS INC 2012-12-05 CN disclosed
EP-1966139-B1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS INC (US) 2011-12-21 EP disclosed
CN-101356156-A Aspartic protease inhibitors VITAE PHARMACEUTICALS INC (US) 2009-01-28 CN disclosed